Author： Ardizzone S. Porro G.B.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.25, Iss.8, 2002-01, pp. : 561-582
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Novel therapies in the treatment of ulcerative colitis
Expert Opinion on Investigational Drugs, Vol. 10, Iss. 7, 2001-07 ,pp. :
Biologic therapies in ulcerative colitis: primi inter pares?
Current Drug Targets, Vol. 19, Iss. 7, 2018-04 ,pp. :
Comparative Tolerability of Therapies for Cytomegalovirus Retinitis
By Walmsley S.
Drug Safety, Vol. 21, Iss. 3, 1999-09 ,pp. :